Aprinoia is merger with Ross Acquisition Corp. (ROSS). Wilbur Ross joins Oliver Renick to discuss this SPAC merger. He notes that this SPAC merger values the combined company at about $320M. He also talks about how Aprinoia studies drugs for Alzheimer's and Parkinson's diseases and has an Alzheimer's drug in late-stage testing. He goes over how ROSS will invest $7.5M through a convertible note. Finally, he mentions how the merger is expected to be completed in the first half of this year. Tune in to find out more about the stock market today.